Stay updated with breaking news from Manitari Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Psychedelics therapy provider Optimind Pharma Corp. entered into an acquisition agreement with Wolf Acquisitions 1.0 Corp., an arm's length private British Columbia corporation with investments in the psychedelics industry and one of its wholly-owned subsidiaries.
Optimind looks to accelerate the adoption of the MindSetting TRIP Protocol for ketamine-assisted therapy and other psychedelic enhanced psychotherapy modalities. Toronto, Ontario--(Newsfile Corp. - September
Toronto, Ontario--(Newsfile Corp. - April 4, 2022) - Loon Energy Corporation (TSXV: LNE) (the "Company" or "Loon") and Optimind Pharma Inc. ("Optimind") have entered into a second amending agreement to
Toronto, Ontario--(Newsfile Corp. - December 23, 2021) - Loon Energy Corporation (TSXV: LNE) (the "Company" or "Loon") and Optimind Pharma Inc. ("Optimind") have entered into an amending agreement to